Fatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease
Fabliha Ahmed Chowdhury(University of Pittsburgh), Adam C. Straub(University of Pittsburgh), Julia Xu(National Institutes of Health), Katherine C. Wood(University of Pittsburgh), Francisco J. Schöpfer(University of Pittsburgh), Bruce Α. Freeman(University of Alabama at Birmingham), Nicole Colussi(University of Pittsburgh), Malini Sharma(Children's Hospital of Philadelphia)
Cited by 13
Related Papers
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
|Journal of Clinical Investigation|1996|2.4k
Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
|Journal of Clinical Investigation|1995|655
Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway
|American Journal of Physiology-Lung Cellular and Molecular Physiology|2000|108
The new International Classification of Diseases 11th edition: a comparative analysis with ICD-10 and ICD-10-CM
|Journal of the American Medical Informatics Association|2020|90
Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine
|Journal of Lipid Research|2013|84